BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/21/2026 6:34:32 AM | Browse: 3 | Download: 0
| Category |
Cell Biology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Hepatic multi-omics insights into Jiangtang tiaozhi formula for glycolipid metabolic disorders
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jia-Yu Lin, Jia-Jie Fu and Di-Guang Wen |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Di-Guang Wen, School of Medical Imaging, Hangzhou Medical College, No 8 Yikang Street, Lin’an District, Hangzhou 310059, Zhejiang Province, China. 2018110626@stu.cqmu.edu.cn |
| Key Words |
Diabetic nephropathy; Combination therapy; Sodium-glucose cotransporter 2 inhibitors; Glucagon-like peptide-1 receptor agonists; Precision medicine; Patient stratification |
| Core Tip |
Diabetic kidney disease (DKD) is a biologically heterogeneous condition, and uniform treatment strategies may not yield equivalent benefits across patients. Recent real-world evidence supports the use of combined sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as part of a layered therapeutic approach. This commentary highlights the importance of precision patient selection, stage-specific evaluation, and mechanism-informed decision-making to optimize combination therapy. Integrating clinical phenotypes with emerging biological insights may facilitate more individualized and effective management of DKD. |
| Citation |
Lin JY, Fu JJ, Wen DG. Hepatic multi-omics insights into Jiangtang tiaozhi formula for glycolipid metabolic disorders. World J Diabetes 2026; In press |
 |
Received |
|
2025-12-28 04:48 |
 |
Peer-Review Started |
|
2025-12-30 07:26 |
 |
First Decision by Editorial Office Director |
|
2026-01-06 06:35 |
 |
Return for Revision |
|
2026-01-06 06:35 |
 |
Revised |
|
2026-01-12 05:45 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-01-21 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-21 06:34 |
 |
Articles in Press |
|
2026-01-21 06:34 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345